Filing Details

Accession Number:
0000784199-23-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-21 08:33:05
Reporting Period:
2023-02-17
Accepted Time:
2023-02-21 08:33:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
784199 Artivion Inc. AORT Surgical & Medical Instruments & Apparatus (3841) 592417093
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1371523 Amy Horton Artivion, Inc.
1655 Roberts Blvd, Nw
Kennesaw GA 30144
Vp, Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-17 17,713 $10.24 117,663 No 4 M Direct
Common Stock Disposition 2023-02-17 15,000 $14.08 102,663 No 4 S Direct
Common Stock Acquisiton 2023-02-17 3,000 $10.24 105,663 No 4 M Direct
Common Stock Disposition 2023-02-17 3,000 $14.13 102,663 No 4 S Direct
Common Stock Disposition 2023-02-17 363 $13.96 102,300 No 4 F Direct
Common Stock Disposition 2023-02-19 1,107 $13.96 101,193 No 4 F Direct
Common Stock Disposition 2023-02-19 258 $13.96 100,935 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Commn Stock Stock Options (Right to buy) Disposition 2023-02-17 17,713 $10.24 17,713 $10.24
Common Stock Stock Options (Right to buy) Disposition 2023-02-17 3,000 $10.24 3,000 $10.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-02-19 2023-02-19 No 4 M Direct
0 2017-02-19 2023-02-19 No 4 M Direct
Footnotes
  1. The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022
  2. Reflects weighted average price. Range of prices were between $13.79 to $15.18. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full informationregarding the number of shares sold at each separate price.
  3. Reflects weighted average price. Range of prices were between $13.65 to $15.18. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full informationregarding the number of shares sold at each separate price
  4. These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.
  5. Represent shares of restricted stock that were withheld for taxes on the grant vest date.
  6. Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017.